Ashwagandha
The best-evidenced ingredient in the formula — and the one carrying a safety signal that deserves more attention than it usually gets.
Ashwagandha in the JellyBlue Formula
Withania somnifera
In one line: If you judge this product on anything, judge it on whether your sleep and stress improve. This is the ingredient most likely to move them.
The formula's strongest evidence by a distance, with repeated placebo-controlled trials on stress, cortisol and sleep — plus a liver-safety point that deserves attention.
The JellyBlue amounts are unpublished, and the format makes that matter
Six ingredients are named. Not one amount appears anywhere, while the source describes "optimal therapeutic doses" and "clinically-informed dosing" in the same breath. Both cannot be true and unverifiable at once.
In a gummy this carries more weight than it would in a capsule. A gummy is mostly gelling agent, sweetener and flavouring, and a typical one weighs only a few grams in total, leaving a small fraction for actives. Several of these ingredients are researched at doses measured in grams. L-arginine trials commonly use 3–6 g daily. Maca studies use 1.5–3 g. Ashwagandha trials use 300–600 mg of standardised extract, tongkat ali 200–400 mg.
Those figures added together exceed what a single gummy can physically hold. That does not make the product useless — but it does mean the claim of therapeutic dosing across all six ingredients in one daily gummy is hard to credit, and impossible to check while no numbers are published.
What Ashwagandha Is in JellyBlue
Ashwagandha is Withania somnifera, a shrub native to India, the Middle East and parts of Africa, used in Ayurvedic practice for centuries. The root is the medicinal part.
Its active compounds are withanolides, a group of steroidal lactones. Quality supplements state a withanolide percentage, and clinical trials have almost always used specific standardised branded extracts rather than plain root powder — a distinction that matters a great deal when comparing a product to the research.
It is classed as an adaptogen, a loose term meaning it is thought to help the body handle stress. The category is vague; in ashwagandha's case there is real evidence beneath it.
What the Ashwagandha Trials Found in JellyBlue
This is the strongest evidence anywhere in the formula.
Stress and cortisol. Multiple randomised, double-blind, placebo-controlled trials have tested standardised root extracts at 300–600 mg daily over six to eight weeks. Several report meaningful reductions in validated perceived-stress scores and in serum cortisol, and the consistency across independent groups is better than most botanical ingredients manage.
Sleep. Trials report improved sleep quality, reduced time to fall asleep and better subjective restfulness, including in people with diagnosed insomnia. Meta-analyses find a small but statistically significant benefit.
Training response. Some trials in men following resistance programmes report greater strength gains and improved recovery against placebo — alongside the training, not instead of it.
Hormones. The testosterone findings quoted most loudly in marketing are the weakest part of the evidence: small trials, often in stressed or infertile men rather than healthy ones, not consistently replicated.
Throughout: modest sample sizes, many trials run by groups with extract-manufacturer relationships, and results tied to specific extracts at stated doses.
Why Ashwagandha Matters More Than the JellyBlue Marketing Suggests in JellyBlue
Worth spelling out, because it reframes the whole product.
Chronic stress raises cortisol, and cortisol antagonises testosterone. Poor sleep independently lowers testosterone — measurably, within about a week of restriction in controlled studies. Both degrade mood, motivation, appetite regulation, training recovery and concentration.
So an ingredient that genuinely improves stress and sleep is working on an upstream cause of most of what this category sells solutions for. That is a stronger proposition than any of the direct claims — and it is the one the marketing spends least time on.
The Ashwagandha Safety Signal in JellyBlue
Ashwagandha is generally well tolerated, and it carries considerations more serious than most botanicals. These get almost no attention in supplement marketing.
Liver injury has been reported. There is a documented set of case reports of ashwagandha-associated liver injury, some serious, and several national regulators have issued advisories about it. It appears rare and is often reversible on stopping, but it is real. Stop taking it and seek medical advice if you develop jaundice, unusually dark urine, persistent nausea, abdominal pain or unexplained fatigue.
- Thyroid. It can raise thyroid hormone levels. Anyone with a thyroid condition or on thyroid medication should speak to a doctor first.
- Autoimmune conditions. It may stimulate immune activity, so medical advice is sensible in conditions like rheumatoid arthritis or Hashimoto's.
- Sedation. It can add to sedatives, benzodiazepines and alcohol.
- Surgery. Discontinue well before any scheduled procedure.
- Digestive upset is the most common mild effect, particularly on an empty stomach.
None of this makes ashwagandha a dangerous ingredient. It does mean any page claiming a formula containing it has no side effects is not being straight with you.
How to read the research on this JellyBlue page
The studies referred to here examined individual ingredients, on their own, at doses the researchers chose. That research explains why an ingredient is a reasonable thing to put in a formula.
It does not show that JellyBlue produces the same outcomes. No clinical trial of this finished gummy has been published, and its ingredient amounts are undisclosed, so the two cannot be connected.
JellyBlue safety: the checks worth making before you order
This is not a neutral multivitamin. Several ingredients act on blood vessels, blood pressure or hormones. The source's comparison table claims the formula has no side effects, which is not something any supplement can support.
- If you take nitrates or nitric-oxide-donating heart medication, speak to a doctor before using this product. L-arginine promotes nitric oxide and epimedium's icariin has vasodilatory activity in laboratory work. Stacking vessel-widening substances on top of nitrates can drop blood pressure dangerously.
- The same applies to blood pressure medication and to prescription erectile dysfunction medicines.
- Ashwagandha has documented case reports of liver injury, can raise thyroid hormone levels, may add to sedatives, and is generally avoided in autoimmune thyroid conditions. Stop and seek advice if you notice jaundice, dark urine or unexplained fatigue.
- L-arginine, grape seed extract and epimedium may all affect bleeding, so mention them alongside anticoagulants or before surgery.
- Tongkat ali is not advised in hormone-sensitive conditions, and independent testing of tongkat ali products has historically found heavy metal contamination and wide variation in extract content.
- L-arginine can trigger recurrences in people prone to cold sores or genital herpes, and should be avoided after a recent heart attack without specialist advice.
- These are gummies containing sugar or sweeteners, worth knowing if you manage blood glucose — and they must be kept away from children, for whom the product is not intended.
This is an adult men's product. Talk to a doctor or pharmacist before starting it, particularly alongside any prescription — advice the brand gives too.
Related JellyBlue Reading
The main ingredients page shows how all six work together, how JellyBlue works covers the groupings and the format's limits, and the benefits page ranks the nine support areas by evidence.
More JellyBlue Ingredients
Add JellyBlue to Your Morning Routine
One gummy a day alongside the sleep, training, nutrition and stress management that do the heavy lifting in men's health. Six ingredients, a format that is easy to keep up, and a 60-day money-back guarantee on every order.
From $49 per bottle · Free US shipping on 3 & 6 bottles · Five bonus guides on qualifying orders
